We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.31B
AUM Growth
-$79.5M
Cap. Flow
-$134M
Cap. Flow %
-10.28%
Top 10 Hldgs %
36.91%
Holding
321
New
34
Increased
51
Reduced
91
Closed
31

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$27.4M
2
UHAL icon
U-Haul Holding Co
UHAL
+$25.6M
3
DVN icon
Devon Energy
DVN
+$25.5M
4
GILD icon
Gilead Sciences
GILD
+$23.1M
5
BA icon
Boeing
BA
+$21M

Sector Composition

Rank Sector Weight
1 Industrials 15.6%
2 Materials 14.21%
3 Communication Services 12.45%
4 Healthcare 10.87%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
26
Caterpillar
CAT
$393B
$27.9M 2.13%
367,599
+20,926
+6% +$1.57M
F icon
27
Ford
F
$57.6B
$23.6M 1.81%
1,877,928
-106,286
-5% -$1.4M
PANW icon
28
Palo Alto Networks
PANW
$263B
$22M 1.69%
1,078,332
+99,504
+10% +$2.3M
MON
29
DELISTED
Monsanto Co
MON
$20.5M 1.57%
+198,180
New +$19.6M
CMCSA icon
30
Comcast
CMCSA
$82.4B
$20.3M 1.55%
621,818
+128,160
+26% +$3.98M
SYK icon
31
Stryker
SYK
$129B
$18.4M 1.41%
153,963
+141,213
+1,108% +$15.8M
NFLX icon
32
Netflix
NFLX
$295B
$15.8M 1.21%
1,732,340
-38,390
-2% -$369K
HBI
33
DELISTED
Hanesbrands
HBI
$15.1M 1.15%
598,909
+2,148
+0.4% +$58.5K
PFE icon
34
Pfizer
PFE
$141B
$14.6M 1.12%
436,267
+416,675
+2,127% +$13.3M
AGN
35
DELISTED
Allergan plc
AGN
$11.9M 0.91%
51,326
+48,299
+1,596% +$11.1M
KO icon
36
Coca-Cola
KO
$360B
$5.96M 0.46%
131,413
-184,040
-58% -$8.32M
MBLY
37
DELISTED
Mobileye N.V.
MBLY
$4.96M 0.38%
107,500
+87,500
+438% +$3.35M
HES
38
DELISTED
Hess
HES
$4.66M 0.36%
77,550
-129,075
-62% -$7.47M
BRK.A icon
39
Berkshire Hathaway Class A
BRK.A
$1.07T
$3.04M 0.23%
14
-14
-50% -$3M
JNJ icon
40
Johnson & Johnson
JNJ
$645B
$2.8M 0.21%
23,066
+4,496
+24% +$511K
LLY icon
41
Eli Lilly
LLY
$1.07T
$2.58M 0.2%
+32,775
New +$2.47M
NEM icon
42
Newmont
NEM
$98.3B
$2.27M 0.17%
+58,050
New +$1.92M
IBM icon
43
IBM
IBM
$204B
$1.93M 0.15%
13,290
+1,046
+9% +$150K
BP icon
44
BP
BP
$110B
$1.47M 0.11%
49,263
+19,551
+66% +$527K
CB icon
45
Chubb
CB
$139B
$1.47M 0.11%
11,250
+8,750
+350% +$1.08M
NVS icon
46
Novartis
NVS
$297B
$1.25M 0.1%
16,852
-111
-0.7% -$7.67K
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$779B
$1.24M 0.09%
5,914
+806
+16% +$167K
GLD icon
48
SPDR Gold Trust
GLD
$132B
$1.13M 0.09%
8,966
-2,050
-19% -$247K
GSK icon
49
GSK
GSK
$104B
$1.09M 0.08%
20,131
NVO
50
Novo Nordisk
NVO
$219B
$1.08M 0.08%
40,000
-10,000
-20% -$274K

Similar funds

R.H. Bluestein & Co's Q2 2016 Portfolio in Review

As of Q2 2016, R.H. Bluestein & Co held 321 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

R.H. Bluestein & Co withdrew a net $134M in Q2 2016, closing 31 positions and reducing 91 holdings. Its most notable exit was Boeing, an estimated $21M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 19% a quarter earlier, followed by Materials and Communication Services.

Against the trend, R.H. Bluestein & Co opened a new position in Monsanto Co worth $20.5M.

  • R.H. Bluestein & Co's largest Q2 2016 buy was Monsanto Co: 198,180 shares worth $20.5M.
  • R.H. Bluestein & Co added most to Barrick Mining in Q2 2016, an estimated $45.6M increase.
  • R.H. Bluestein & Co's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $27.4M.
  • R.H. Bluestein & Co fully exited Boeing in Q2 2016, selling an estimated $21M.
  • R.H. Bluestein & Co's ten largest holdings make up 37% of its $1.31B portfolio in Q2 2016.
  • R.H. Bluestein & Co opened 34 new positions and closed 31 in Q2 2016.
  • R.H. Bluestein & Co's portfolio value fell 5.7% quarter-over-quarter to $1.31B.

Based on R.H. Bluestein & Co's 13F filing for Q2 2016, filed 12 Aug 2016.